Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy, Haematologica, April 2014, Ferrata Storti Foundation (Haematologica),
DOI: 10.3324/haematol.2013.099341.
You can read the full text:

Read

Contributors

The following have contributed to this page